Keywords: Glucagon-like peptide 1 receptor agonists, Health disparities, Off-label prescriptions, Social determinants of health Clinical Significance
The FDA issued a warning letter regarding BPC-157 compounding in 2023, noting that bulk drug substances used in 503A compounding must meet specific quality standards
Future research should focus on better understanding the mechanisms of liraglutide hypersensitivity, including the roles of immunological and nonimmunological factors
The early separation of the cumulative incidence functions reflects the drugs rapid mechanism of action, a finding supported by preclinical studies (in rodents and vervet monkeys) and human data showing immediate changes in craving and substance use after administration of a GLP-1 receptor agonist.3116667 Our treatment adherence analyses are consistent with this, showing a constant relative effect that is established early and sustained during adherence (eg, risk ratio 0.76 for protocol 1 at the end of year 1, 2, and 3)
Zepbound for weight management) represents a distinct class as a dual GIP/GLP-1 receptor agonist
